5-((glucopyranosyloxy)methyl)uracil: a base found in the DNA of Trypanosoma brucei [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 124162 |
| MeSH ID | M0225451 |
| Synonym |
|---|
| beta-ghmu |
| 53910-96-6 |
| 1-[(4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]pyrimidine-2,4-dione |
| beta-d-glucosylhydroxymethyluracil |
| 5-((glucopyranosyloxy)methyl)uracil |
| dna base j |
| thymidine, alpha-(beta-d-glucopyranosyloxy)- |
| j base |
| DTXSID90968701 |
| [1-(2-deoxypentofuranosyl)-4-hydroxy-2-oxo-1,2-dihydropyrimidin-5-yl]methyl hexopyranoside |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (2.22) | 18.7374 |
| 1990's | 11 (24.44) | 18.2507 |
| 2000's | 16 (35.56) | 29.6817 |
| 2010's | 16 (35.56) | 24.3611 |
| 2020's | 1 (2.22) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.80) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 5 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 40 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||